The cost-effectiveness of zemplar in the Netherlands

被引：0
作者：
Nuijten, MJ
Siegert, C
机构：
[1] Ars Accessus Medica Erasmus Univ, Rotterdam, Netherlands
[2] St Lucas Andreas Hosp, Amsterdam, Netherlands
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64336-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A7 / A8
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness of laser Doppler imaging in burn care in the Netherlands
    Hop, M. Jenda
    Hiddingh, Jakob
    Stekelenburg, Carlijn
    Kuipers, Hester C.
    Middelkoop, Esther
    Nieuwenhuis, Marianne K.
    Polinder, Suzanne
    van Baar, Margriet E.
    BMC SURGERY, 2013, 13
  • [42] COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN THE NETHERLANDS
    Thurston, S. J.
    Webb, K.
    Ong, S.
    Meerding, W. J.
    van Hout, B. A.
    VALUE IN HEALTH, 2009, 12 (07) : A335 - A335
  • [43] BEYOND CERVICAL CANCER: THE COST-EFFECTIVENESS OF HPV VACCINATION IN THE NETHERLANDS
    Setiawan, D.
    Cao, Q.
    Westra, T. A.
    Postma, M. J.
    VALUE IN HEALTH, 2016, 19 (07) : A416 - A417
  • [44] Response on "RE: Cost-effectiveness of pertussis booster vaccination in the Netherlands"
    Rozenbaum, Mark H.
    Postma, Maarten J.
    VACCINE, 2013, 31 (16) : 2024 - 2024
  • [45] Quality of Care and Cost-effectiveness: Optimizing Wound Care in the Netherlands
    Brekelmans, Wouter
    van Der Burg, Boudewijn L. S. Borger
    Tolen, Nicole J.
    Hoencamp, Rigo
    ADVANCES IN SKIN & WOUND CARE, 2022, 35 (12) : 669 - 673
  • [46] Cost-effectiveness analysis of sacral neuromodulation for faecal incontinence in the Netherlands
    van Wunnik, B. P. W.
    Visschers, R. G. J.
    van Asselt, A. D. I.
    Baeten, C. G. M. I.
    COLORECTAL DISEASE, 2012, 14 (12) : e807 - e814
  • [47] Cost-effectiveness of screening for abdominal aortic aneurysm in the Netherlands and Norway
    Spronk, S.
    van Kempen, B. J. H.
    Boll, A. P. M.
    Jorgensen, J. J.
    Hunink, M. G. M.
    Kristiansen, I. S.
    BRITISH JOURNAL OF SURGERY, 2011, 98 (11) : 1546 - 1555
  • [48] COST-EFFECTIVENESS OF A COCOONING IMMUNIZATION STRATEGY AGAINST PERTUSSIS FOR THE NETHERLANDS
    Westra, T. A.
    de Vries, R.
    Tamminga, H. J.
    Wilschut, J. C.
    Sauboin, C.
    Postma, M. J.
    VALUE IN HEALTH, 2009, 12 (07) : A425 - A426
  • [49] Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
    Rozenbaum, Mark H.
    Mangen, Marie-Josee J.
    Giaquinto, Carlo
    Wilschut, Jan C.
    Hak, Eelko
    Postma, Maarten J.
    BMC PUBLIC HEALTH, 2011, 11
  • [50] Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands
    de Boer, Pieter T.
    de lange, Marit M. A.
    Wielders, Cornelia C. H.
    Dijkstra, Frederika
    van Roeden, Sonja E.
    Bleeker-Rovers, Chantal P.
    Oosterheert, Jan Jelrik
    Schneeberger, Peter M.
    van der Hoek, Wim
    EMERGING INFECTIOUS DISEASES, 2020, 26 (02) : 238 - 246
12345